These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20097381)

  • 21. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
    Eskicorapci SY; Tuncay L
    J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
    [No Abstract]   [Full Text] [Related]  

  • 22. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer.
    Shagisultanova EI; Novikova IA; Sidorenko YS; Marchenko GN; Strongin AY; Malkhosyan SR
    Anticancer Res; 2004; 24(1):199-201. PubMed ID: 15015597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.
    Nakazato H; Suzuki K; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Ito K; Kurokawa K; Yamanaka H
    Anticancer Res; 2003; 23(3C):2897-902. PubMed ID: 12926131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.
    Suarez BK; Gerhard DS; Lin J; Haberer B; Nguyen L; Kesterson NK; Catalona WJ
    Cancer Res; 2001 Jul; 61(13):4982-4. PubMed ID: 11431329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
    Walsh PC
    J Urol; 2009 Mar; 181(3):1499; author reply 1499-500. PubMed ID: 19157429
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962.
    Cheng T; Heng DY; Stewart D
    J Urol; 2009 Nov; 182(5):2531-2; discussion 2532-4. PubMed ID: 19766252
    [No Abstract]   [Full Text] [Related]  

  • 28. Measurement of the digit lengths and the anogenital distance in mice.
    Manno FA
    Physiol Behav; 2008 Jan; 93(1-2):364-8. PubMed ID: 18054055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
    Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Prostate cancer severity among low income, uninsured men. D. C. Miller, M. S. Litwin, J. Bergman, S. Stepanian, S. E. Connor, L. Kwan and W. J. Aronson. J Urol 2009; 181: 579-584.
    Watson RA
    J Urol; 2010 Mar; 183(3):1259-60; author reply 1260. PubMed ID: 20097378
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy: J. A. Smith, Jr., R. C. Chan, S. S. Chang, S. D. Herrell, P. E. Clark, R. Baumgartner and M. S. Cookson. J Urol 2007; 178: 2385-2390.
    Masieri L; Minervini A; Serni S; Carini M
    J Urol; 2008 Nov; 180(5):2257; author reply 2257. PubMed ID: 18823916
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR; Di Silverio F; Gentile V
    Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
    Srivastava DS; Mandhani A; Mittal B; Mittal RD
    BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
    Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
    Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.
    Medeiros RM; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Ferreira P; Lopes C
    Clin Cancer Res; 2002 Nov; 8(11):3433-7. PubMed ID: 12429631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
    Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
    Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.